Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Hansson

Showing results (71-80 of 199) with videos related to

Pageof 20
Sort By:
Journal of Nursing Management|December 24, 2019
Leadership in specialist palliative home care teams: A qualitative studyAnna Klarare, Susanne Lind, Johan Hansson, et al.
BMC Cancer|August 31, 2017
Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanomaJohan Falkenius, Hemming Johansson, Rainer Tuominen, et al.
Clinical Chemistry|November 25, 2005
Detection of MC1R polymorphisms with protease-mediated allele-specific extension as an alternative to direct sequencingMax Käller, Rainer Tuominen, Afshin Ahmadian, et al.
Journal of the National Cancer Institute|June 12, 2016
Germline CDKN2A Mutation Status and Survival in Familial Melanoma CasesHildur Helgadottir, Veronica Höiom, Rainer Tuominen, et al.
Palliative & Supportive Care|July 23, 2016
Experiences of security and continuity of care: Patients' and families' narratives about the work of specialized palliative home care teamsAnna Klarare, Birgit H Rasmussen, Bjöörn Fossum, et al.
European Journal of Cancer Care|October 10, 2018
Actions helping expressed or anticipated needs: Patients with advanced cancer and their family caregivers' experiences of specialist palliative home care teamsAnna Klarare, Birgit H Rasmussen, Bjöörn Fossum, et al.
The Journal of Investigative Dermatology|April 2, 2010
MicroRNA expression profiles associated with mutational status and survival in malignant melanomaStefano Caramuta, Suzanne Egyházi, Monica Rodolfo, et al.
International Journal of Cancer|May 7, 2015
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignanciesHildur Helgadottir, Veronica Höiom, Rainer Tuominen, et al.
BMC Health Services Research|April 19, 2015
Implementation of evidence-based rehabilitation for non-specific back pain and common mental health problems: a process evaluation of a nationwide initiativeElisabeth Björk Brämberg, Charlotte Klinga, Irene Jensen, et al.
Lakartidningen|March 16, 2013
[Synchronous multiple primary melanoma are often missed. Increased attention to the patient's entire skin is required for early diagnosis]Jan Lapins, Lennart Emtestam, Mari-Anne Hedblad, et al.
Pageof 20

Showing results (71-80 of 199) with videos related to

Sort By:
Pageof 20
Journal of Nursing Management|December 24, 2019
Leadership in specialist palliative home care teams: A qualitative studyAnna Klarare, Susanne Lind, Johan Hansson, et al.
BMC Cancer|August 31, 2017
Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanomaJohan Falkenius, Hemming Johansson, Rainer Tuominen, et al.
Clinical Chemistry|November 25, 2005
Detection of MC1R polymorphisms with protease-mediated allele-specific extension as an alternative to direct sequencingMax Käller, Rainer Tuominen, Afshin Ahmadian, et al.
Journal of the National Cancer Institute|June 12, 2016
Germline CDKN2A Mutation Status and Survival in Familial Melanoma CasesHildur Helgadottir, Veronica Höiom, Rainer Tuominen, et al.
Palliative & Supportive Care|July 23, 2016
Experiences of security and continuity of care: Patients' and families' narratives about the work of specialized palliative home care teamsAnna Klarare, Birgit H Rasmussen, Bjöörn Fossum, et al.
European Journal of Cancer Care|October 10, 2018
Actions helping expressed or anticipated needs: Patients with advanced cancer and their family caregivers' experiences of specialist palliative home care teamsAnna Klarare, Birgit H Rasmussen, Bjöörn Fossum, et al.
The Journal of Investigative Dermatology|April 2, 2010
MicroRNA expression profiles associated with mutational status and survival in malignant melanomaStefano Caramuta, Suzanne Egyházi, Monica Rodolfo, et al.
International Journal of Cancer|May 7, 2015
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignanciesHildur Helgadottir, Veronica Höiom, Rainer Tuominen, et al.
BMC Health Services Research|April 19, 2015
Implementation of evidence-based rehabilitation for non-specific back pain and common mental health problems: a process evaluation of a nationwide initiativeElisabeth Björk Brämberg, Charlotte Klinga, Irene Jensen, et al.
Lakartidningen|March 16, 2013
[Synchronous multiple primary melanoma are often missed. Increased attention to the patient's entire skin is required for early diagnosis]Jan Lapins, Lennart Emtestam, Mari-Anne Hedblad, et al.
Pageof 20